Your browser doesn't support javascript.
loading
CD44 is a potential immunotherapeutic target and affects macrophage infiltration leading to poor prognosis.
Liu, Shuangqing; Liu, Zehan; Shang, Aichen; Xun, Jing; Lv, Zongjing; Zhou, Siying; Liu, Cui; Zhang, Qi; Yang, Yuming.
Afiliação
  • Liu S; Tianjin Medical University Nankai Hospital, Tianjin, 300070, China.
  • Liu Z; Tianjin Medical University Nankai Hospital, Tianjin, 300070, China.
  • Shang A; Section for HepatoPancreatoBiliary Surgery, Department of General Surgery, The Third People's Hospital of Chengdu, Affiliated Hospital of Southwest Jiaotong University and The Second Affiliated Hospital of Chengdu, Chongqing Medical University, Chengdu, 610031, China.
  • Xun J; Tianjin Medical University Nankai Hospital, Tianjin, 300070, China.
  • Lv Z; Department of Pathology, Sino-Singapore Eco-City Hospital of Tianjin Medical University, Tianjin, 300456, China.
  • Zhou S; Tianjin Key Laboratory of Acute Abdomen Disease Associated Organ Injury and ITCWM Repair, Institute of Acute Abdominal Diseases, Tianjin Nankai Hospital, Tianjin, China.
  • Liu C; Tianjin Medical University Nankai Hospital, Tianjin, 300070, China.
  • Zhang Q; Tianjin Medical University Nankai Hospital, Tianjin, 300070, China.
  • Yang Y; Tianjin Medical University Nankai Hospital, Tianjin, 300070, China.
Sci Rep ; 13(1): 9657, 2023 06 14.
Article em En | MEDLINE | ID: mdl-37316699

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Antígeno B7-H1 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Antígeno B7-H1 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article